adding bcnu ( or perhaps tri-iodothyronine ) to medium field ( less than 135 mc ) and moderate dose irradiation ( 5 000 rad in 25 treatments in 33 days ) may improve the outlook for patients with glioblastoma multiforme .
C0007257
bcnu
C0017636
glioblastoma multiforme